Amgen Inc. News
Dice Therapeutics Aces Psoriasis Study and Stock Surges. What's Next?
Dice Therapeutics shares leaped on positive data for its lead drug candidate. What comes next?
How Far Will AbbVie's Humira Revenue Fall in 2023?
The world's best-selling drug begins losing patent protections next year. AbbVie's revenue could take years to recover.
Bristol Myers Squibb Shakes Up Key Biotech Battleground
The FDA approval of Sotyktu for psoriasis has both ignited and dampened prospects for smaller biotech stocks.
Bristol Myers Squibb Stock: Here's the Key Breakout Level to Watch
Bristol Myers Squibb received good news from the FDA, but only enough to put a key resistance level in play. Here's the level it needs to clear.
Stock Market Today - 9/12: Stocks End Higher Amid Dollar Retreat With Inflation Data In Focus
Stocks finished higher after snapping a three-week losing streak as the dollar continues to slide against its global currency peers.
Bristol Myers Stock Surges After FDA Approves New Plaque Psoriasis Treatment; Amgen Slides
“We believe Sotyktu is a breakthrough in the treatment of patients suffering from moderate-to-severe plaque psoriasis," said Bristol Myers' chief medical officer Samit Hirawat.
Biosimilars Are Saving America $1 Billion Per Month
Competitive drug prices are great for consumers. Turns out, they're good for industry, too.
Stock Market Today – 8/3: Stocks End Higher as Investors Await Key Economic Data
U.S. stocks finished the session higher, reversing two consecutive days of losses, as investors looked past Pelosi's Taiwan visit and ahead to key economic data.
Ford Unveils Big Electric Vehicle Surprise in November
Ford's electric vehicle sales jumped in November, but retail sales take a big dive.
3 Mistakes to Avoid When Buying Disney World Tickets
If you're planning to visit Magic Kingdom, Epcot, Hollywood Studios, or Animal Kingdom, you need to know these things first.
Amid Twitter Chaos, Elon Musk Begs Readers for This One Thing
After a wild period before and after the official purchase of Twitter, the company's new CEO settles on a request he has of the microblogging site's users.
Royal Caribbean's CEO on How the Cruise Line Got Through Covid
Covid caused a long dark period for the cruise industry from March 2020 through July 2021. Michael Bayley talks about what that time was like.